Bokus

Haitao Pan – författare

Visar alla böcker från författaren Haitao Pan. Handla med fri frakt och snabb leverans.

4 produkter

  1. Haitao Pan, Ying Yuan - Bayesian Adaptive Design for Immunotherapy and Targeted Therapy, Inbunden. Tillgänglighet: Lägg i varukorg

    Bayesian Adaptive Design for Immunotherapy and Targeted Therapy

    Av Haitao Pan, Ying Yuan

    Inbunden, 2023

    1692 kr

    Lägg i varukorg

    This book provides a comprehensive review of novel adaptive trial designs for targeted therapies and immunotherapies. This book covers a wide range of novel statistical designs for various clinical settings, including early phase dose-escalation study, proof-of-concept trials, and confirmatory …

  2. Haitao Pan, Ying Yuan - Bayesian Adaptive Design for Immunotherapy and Targeted Therapy. Tillgänglighet: Lägg i varukorg

    Bayesian Adaptive Design for Immunotherapy and Targeted Therapy

    Av Haitao Pan, Ying Yuan

    2023

    686 kr

    Lägg i varukorg

  3. Ying Yuan, Haitao Pan - Bayesian Adaptive Design for Immunotherapy and Targeted Therapy, E-bok. Tillgänglighet: Lägg i varukorg

    Bayesian Adaptive Design for Immunotherapy and Targeted Therapy

    Av Ying Yuan, Haitao Pan

    E-bok, 2023

    2111 kr

    Lägg i varukorg

    This book provides a comprehensive review of novel adaptive trial designs for targeted therapies and immunotherapies. This book covers a wide range of novel statistical designs for various clinical settings, including early phase dose-escalation study, proof-of-concept trials, and confirmatory …

  4. Haitao Pan, Ying Yuan - Bayesian Adaptive Design for Immunotherapy and Targeted Therapy, Häftad. Tillgänglighet: Lägg i varukorg

    Bayesian Adaptive Design for Immunotherapy and Targeted Therapy

    Av Haitao Pan, Ying Yuan

    Häftad, 2024

    1692 kr

    Lägg i varukorg

    This book provides a comprehensive review of novel adaptive trial designs for targeted therapies and immunotherapies. This book covers a wide range of novel statistical designs for various clinical settings, including early phase dose-escalation study, proof-of-concept trials, and confirmatory …